We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Leash and corn

13 January 2014 By Robert Cyran

Productive drug labs rarely survive M&A intact. The market rightly loves Alnylam’s purchase of assets from Merck and simultaneous $700 mln sale of a chunk of itself to Sanofi. Instead of killing the golden goose to try to harvest eggs, Sanofi’s deal could encourage production.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)